skip to main content skip to accessibility policy

IP Cases & Commentary – Details

23 March 2012

UK Patent Box Wins Over GSK

Doug Ealey

GlaxoSmithKline plans to invest £500m in a new plant in the UK in what it describes as “one of the largest commitments to the UK life sciences sector in recent years”.

GSK’s announcement follows the Chancellor’s confirmation in the Budget that the Government will proceed with the Patent Box system, which provides a reduced tax rate (10%) for the proceeds of IP and IP protected goods. GSK CEO, Sir Andrew Witty, said, “The introduction of the patent box has transformed the way in which we view the UK as a location for new investments, ensuring that the medicines of the future will not only be discovered, but can also continue to be made here in Britain”.

Bookmark and Share

Follow us

Newsletter subscriptions

In support of our environmental policy we encourage email subscriptions to receive our patent and trade mark newsletters as soon as they are published. Please send your contact details to

For RSS users

Our RSS news feeds allow you to see when we have added new content to our website so you can get the latest site updates in one place, as soon as they are published.

Social media

Privacy Policy

We are committed to protecting and respecting your privacy. To understand our views and practices regarding your personal data and how we will treat it please see